Document Detail

Perinatal aspects of iron metabolism.
MedLine Citation:
PMID:  12477276     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: The highly variable iron status of preterm infants combined with their risk for iron deficiency and toxicity warrants careful monitoring and support in the newborn and postdischarge periods.
R Rao; M K Georgieff
Related Documents :
16988136 - Milk folate secretion is not impaired during iron deficiency in humans.
7472906 - Determination of iron absorption using erythrocyte iron incorporation of two stable iso...
20504976 - Combined iron/folic acid supplements and malaria prophylaxis reduce neonatal mortality ...
11320046 - Blood transfusion increases radical promoting non-transferrin bound iron in preterm inf...
17703786 - Effect of evaluation threat on procrastination behavior.
23484666 - Preliminary assessment of the risk linked to furan ingestion by babies consuming only r...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992). Supplement     Volume:  91     ISSN:  0803-5326     ISO Abbreviation:  Acta Paediatr Suppl     Publication Date:  2002  
Date Detail:
Created Date:  2002-12-12     Completed Date:  2003-03-18     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9315043     Medline TA:  Acta Paediatr Suppl     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  124-9     Citation Subset:  IM    
Division of Neonatology, Department of Pediatrics and Center for Neurobehavioral Development, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia, Iron-Deficiency / diagnosis*,  etiology,  therapy*
Combined Modality Therapy
Erythrocyte Transfusion / methods
Erythropoietin / therapeutic use
Fetal Growth Retardation / complications,  diagnosis
Follow-Up Studies
Gestational Age
Infant, Newborn
Infant, Premature*
Iron Compounds / adverse effects,  therapeutic use
Iron Metabolism Disorders / complications,  diagnosis*,  therapy*
Iron Overload / prevention & control*
Maternal-Fetal Exchange
Recombinant Proteins
Risk Assessment
Risk Factors
Severity of Illness Index
Grant Support
Reg. No./Substance:
0/Iron Compounds; 0/Recombinant Proteins; 11096-26-7/Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study li...
Next Document:  Oxidant injury in neonatal erythrocytes during the perinatal period.